Working with TipRanks
Follow Us
Stock Ideas
Daily Updates
Calendars
Education
About Us
Working with TipRanks
Follow Us
INVO Bioscience (INVO)
NASDAQ:INVO
INVO Bioscience (INVO) Stock Price & Analysis
69 Followers
INVO Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.30 - $1.65
Previous Close$0.3
Volume102.70K
Average Volume (3M)195.26K
Market Cap
$4.19M
Enterprise Value$3.85M
Total Cash (Recent Filing)$2.19M
Total Debt (Recent Filing)$1.84M
Price to Earnings (P/E)-0.3
Beta1.66
Next Earnings
Aug 14, 2023EPS Estimate
-$0.21Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.87
Shares Outstanding13,971,283
10 Day Avg. Volume56,351
30 Day Avg. Volume195,263
Standard Deviation0.24
R-Squared0.08
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)52.12
Price to Sales (P/S)14.10
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue4.02
Enterprise Value/Gross Profit7.19
Enterprise Value/Ebitda-0.78
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusModerate Buy
Number of Analyst Covering1
INVO Bioscience News
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
INVO FAQ
What was INVO Bioscience’s price range in the past 12 months?
INVO Bioscience lowest stock price was $0.30 and its highest was $1.65 in the past 12 months.
What is INVO Bioscience’s market cap?
Currently, no data Available
When is INVO Bioscience’s upcoming earnings report date?
INVO Bioscience’s upcoming earnings report date is Aug 14, 2023 which is in 76 days.
How were INVO Bioscience’s earnings last quarter?
Currently, no data Available
Is INVO Bioscience overvalued?
According to Wall Street analysts INVO Bioscience’s price is currently Overvalued.
Does INVO Bioscience pay dividends?
INVO Bioscience does not currently pay dividends.
What is INVO Bioscience’s EPS estimate?
INVO Bioscience’s EPS estimate is -$0.21.
How many shares outstanding does INVO Bioscience have?
INVO Bioscience has 13,971,283 shares outstanding.
What happened to INVO Bioscience’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of INVO Bioscience?
Currently, no hedge funds are holding shares in INVO
---
INVO Bioscience Stock Smart Score
Not Ranked
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
-71.15%
12-Months-Change
Fundamentals
Return on Equity
-375.77%
Trailing 12-Months
Asset Growth
-27.81%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
INVO Bioscience
INVO BioScience, Inc. focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Medford, MA.
---
Top 5 ETFs holding INVO
Currently, no data available
Please return soon. This page is being updated.
Up to five ETFs with an Outperform Smart Score that hold INVO. The ETFs are listed according to market value of INVO within the ETF
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Bluejay Diagnostics
―
Tivic Health Systems
―
Invacare
―
Neurometrix
―
Brain Scientific
―
---